Realty Income Corp (O) Stock Price Today
Aura AI Summary
Key Stats
- $58.91BMarket Cap
- -Volume
- Real EstateSector
- $67.5652W High
- $55.9352W Low
- -Typical Hold Time
- $88.71BEnterprise Value
- 5.15%Div Yield
- -Trading Activity
Track Realty Income Corp (O) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Realty Income Corp has traded between a low of $55.93 and a high of $67.56, highlighting its annual price range. Buy and sell Realty Income Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Realty Income Corp
Realty Income owns roughly 11,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, office, manufacturing, and distribution properties, which make up roughly 17% of revenue.
Most Recent News
Document AI market to nearly double to $27.62B by 2030, driven by AI and automation in regulated industries.
The Document AI market is forecasted to grow from $14.66 billion in 2025 to $27.62 billion by 2030, at a CAGR of 13.5%. This growth is fueled by organizations adopting AI technologies like intelligent document processing, generative AI, and workflow ...

AI in orthopedic surgery market to hit $0.87B by 2030 with 27.2% CAGR, driven by tech advances and rising musculoskeletal disorders
The AI in orthopedic surgery market is projected to grow from $0.26 billion in 2025 to $0.87 billion by 2030, at a CAGR of 27.2%. Growth is fueled by increased orthopedic surgeries, innovations in medical imaging, adoption of minimally invasive techn...

Generative AI in drug discovery market to reach $0.86B by 2030, growing at 27% CAGR driven by faster drug development and AI advances
The generative AI market in drug discovery is expanding rapidly, expected to grow from $0.33 billion in 2026 to $0.86 billion by 2030 with a 27% CAGR. Growth is fueled by rising drug development costs, advances in AI technologies like deep learning, ...
